The vaccine also induced a broad T-cell response, a part of the immune system believed to be involved in maintaining long-term immunity, and generated fewer side effects among recipients, Valneva said. No serious adverse events were reported across the trial.
https://sg.news.yahoo.com/valneva-vaccin...49137.html
https://sg.news.yahoo.com/valneva-vaccin...49137.html